Aleutian mink disease virus and humans

Emerging Infectious Diseases

Volumn 15, Issue 12, 2009, Pages 2040-2042

  Jepsen, Jørgen R ^a   D'Amore, Francesco ^b   Baandrup, Ulrik ^c   Clausen, Michael Roost ^b   Gottschalck, Elisabeth ^d   Aasted, Bent ^e  

^a Clinical Diagnostics Hospital of South West Jutland   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

^d University of Copenhagen ^*  (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALEUTIAN MINK DISEASE VIRUS ANTIBODY; ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA;

ALEUTIAN MINK DISEASE; ALEUTIAN MINK DISEASE VIRUS; ANAMNESIS; ARTICLE; BIOPSY; CASE REPORT; CLINICAL FEATURE; ELECTRON MICROSCOPY; ELECTROPHORESIS; HISTOPATHOLOGY; HUMAN; MICROANGIOPATHY; POLYMERASE CHAIN REACTION; VASCULAR DISEASE;

ADULT; ALEUTIAN MINK DISEASE; ALEUTIAN MINK DISEASE VIRUS; ANIMALS; ANTIBODIES, VIRAL; DNA, VIRAL; HUMANS; MALE; MIDDLE AGED; MINK;

EID: 73949160768     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1512.090514     Document Type: Article

References (15)

1. Anderson MJ. Human parvovirus infections. J Virol Methods. 1987;17:175-81. DOI: 10.1016/0166-0934(87)90080-2
2. Aasted B. Aleutian disease of mink. Virology and immunology. Acta Pathol Microbiol Immunol Scand Sect C. 1985;93(suppl 287):1-47.
3. Porter HG, Porter DD, Larsen AE. Aleutian disease in ferrets. Infect Immun. 1982;36:379-86.
4. Porter DD, Larsen AE, Porter HG. The pathogenesis of Aleutian disease of mink. III. Immune complex arteritis. Am J Pathol. 1973;71:331-44.
5. Alexandersen S, Bloom ME, Wolfinbarger JB. Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol. 1988;62:1495-517.
6. Mori S, Nose M, Miyazawa M, Kyogoku M, Wolfinbarger JB, Bloom ME. Emerging concepts in the pathogenesis of Aleutian mink disease: identification of the sites of viral replication and analysis of two types of renal lesions. In: Yoshida TO, Wilson JM, editors. Molecular approaches to the study and treatment of human diseases. Proceedings of the International Symposium on Genetic Intervention in Diseases with Unknown Etiology. 1990 Nov 30-Dec 1; Tokyo. New York: Elsevier Science Publishing Company; 1992. p. 301-8.
7. Porter DD, Larsen AE, Porter HG. Aleutian disease of mink. Adv Immunol. 1980;29:261-86. DOI: 10.1016/S0065-2776(08)60046-2
8. Viuff B, Aasted B, Alexandersen S. Role of alveolar type II cells and of surfactant-associated protein C mRNA levels in the pathogenesis of respiratory distress in mink kits infected with Aleutian mink disease parvovirus. J Virol. 1994;68:2720-5.
9. Chapman I, Jimenez FA. Aleutian-mink disease in man. N Engl J Med. 1963;269:1171-4.
10. Helmbolt CF, Kenyon AJ, Dessel BH. The comparative aspects of Aleutian mink disease (AD). In: Gajdusek DC, Gibbs CJ, Alpers MP, editors. Slow, latent, and temperate virus infections. Washington: US Department of Health, Education and Welfare; 1965. p. 315-9.
11. Mcguire TC, Crawford TB. Antibodies to Aleutian disease virus in human sera. J Infect Dis. 1980;142:625.
12. Kanno H, Wolfinbarger JB, Bloom ME. Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection. J Virol. 1993;67:7017-24.
13. Aasted B, Alexandersen S, Cohn A, Hansen M. Counter current line absorption immunoelectrophoresis is an alternative diagnostic screening test to counter current electrophoresis in Aleutian disease (AD) eradication programs. Acta Vet Scand. 1986;27:410-20.
14. Rosenstock JL, Markowitz GS, Valeri AM, Sacci G, Appel GB, D'Agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathological features. Kidney Int. 2003;63:1450-61. DOI: 10.1046/j.1523-1755.2003.00853.x
15. Wiklund K, Lindefors BM, Holm LE. Risk of malignant lymphoma in Swedish agricultural and forestry workers. Br J Ind Med. 1988;45:19-24.